Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 0.00 | 14.20 |
| PEG Ratio (TTM) | N/A | -4.49 |
| P/S Ratio (TTM) | 0.00 | 2.13 |
| P/B Ratio (TTM) | 0.00 | 5.93 |
| P/FCF Ratio (TTM) | 0.00 | 20.99 |
| Price to 5YR AVG Earnings Ratio | N/A | 25.72 |
| Price to 5YR AVG FCF Ratio | N/A | 28.65 |
Profitability (65%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 10.57% | 9.08% |
| ROE (TTM) | 38.03% | 39.43% |
| Net Profit Margin (TTM) | 62.14% | 13.53% |
| ROIC 5YR AVG | N/A | 14.73% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -75.56% | -134.81% | N/A |
| Revenue | 107.30% | 111.51% | N/A |
| Net Income | -94.70% | -114.45% | N/A |
| Cash Flow | 23.21% | -129.03% | N/A |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 7.68 | 2.33 |
| Quick Ratio (TTM) | 4.72 | 1.85 |
| D/E Ratio (TTM) | 1.14 | 2.10 |
| Interest Coverage (TTM) | -4.89 | 13.71 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | N/A | 3.39 |
| LTL to 5YR AVG FCF | N/A | 7.42 |
| Shares Outstanding Growth 5YR AVG | N/A | -2.06% |